Sudarshan Pharma

Market Cap: Micro Cap
Industry: Specialty Chemicals
ISIN: INE00TV01023
NSEID:
BSEID: 543828

INR

26.20

-0.44 (-1.65%)

BSENSE

Dec 05

BSE+NSE Vol: 24000

{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.20",
    "chg": -0.44,
    "chgp": "-1.65%",
    "dir": -1,
    "prev_price": "26.64",
    "mcapval": "645.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE00TV01023",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 24000,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-sees-mild-shift-in-technical-momentum-amid-bearish-trends-3747831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SudarshanPharma_technicaldot_3747831.png",
        "date": "2025-12-05 08:11:29",
        "description": "Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting changes in market sentiment and price dynamics. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish technical trend, accompanied by mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses these developments in the context of the company’s price performance and broader market conditions."
      },
      {
        "title": "Is Sudarshan Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sudarshan-pharma-technically-bullish-or-bearish-3745762",
        "imagepath": "",
        "date": "2025-12-04 08:53:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 03 Dec 2025, Sudarshan Pharma’s technical trend has transitioned from mildly bearish to outright bearish. This shift signals increased selling pressure and a weakening momentum in the stock’s price action. The change is significant given the stock’s recent price behaviour, which has seen a decline from its previous close of ₹27.28 to a current level near ₹26.35.</p>\n<p>The stock’s 52-week high stands at ₹53.50, while the 52-week low is ₹22.33, indicating a wide trading range and substantial volatility over the past year. Today’s intraday range between ₹26.18 and ₹28.00 further highlights the stock’s struggle to regain upward momentum.</p>\n<p><strong>Key Technical Indicators Paint a Bearish Picture</strong></p>\n<p>Examining the Moving Average..."
      },
      {
        "title": "Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-faces-bearish-momentum-amid-technical-downturn-3745552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SudarshanPharma_technicaldot_3745552.png",
        "date": "2025-12-04 08:12:44",
        "description": "Sudarshan Pharma Industries has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the specialty chemicals sector. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a complex interplay of price movements and indicator signals that investors should carefully consider."
      },
      {
        "title": "Sudarshan Pharma Industries Sees Shift in Technical Momentum Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-sees-mixed-technical-signals-amid-price-momentum-shift-3743067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SudarshanPharma_technicaldot_3743067.png",
        "date": "2025-12-03 08:09:20",
        "description": "Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum as recent market data reveals changes in key indicators such as MACD, RSI, and moving averages. The stock’s price movement and technical signals suggest a nuanced market assessment amid broader sector and benchmark trends."
      },
      {
        "title": "Sudarshan Pharma Industries Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-hits-upper-circuit-amidst-unprecedented-buying-interest-3738835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SudarshanPharma_only_buyers_3738835.png",
        "date": "2025-12-01 14:45:42",
        "description": "Sudarshan Pharma Industries has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the specialty chemicals sector."
      },
      {
        "title": "Sudarshan Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-stock-downgraded-to-sell-amid-weak-financial-and-technical-signals-3738067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SudarshanPharma_mojoScore_3738067.png",
        "date": "2025-12-01 10:09:16",
        "description": "Sudarshan Pharma, a microcap player in the Specialty Chemicals sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced view of its recent financial and technical performance. The stock’s assessment now incorporates a blend of stable financial trends, attractive valuation, average quality indicators, and bearish technical signals, providing investors with a comprehensive perspective on its current standing."
      },
      {
        "title": "Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-faces-severe-selling-pressure-amid-lower-circuit-3735499",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SudarshanPharma_only_sellers_3735499.png",
        "date": "2025-11-28 11:10:57",
        "description": "Sudarshan Pharma Industries has encountered significant selling pressure in the latest trading session, with the stock registering a sharp decline and exhibiting a complete absence of buyers. This distress selling signals heightened investor caution as the stock breaks a four-day streak of gains and trades well below key moving averages."
      },
      {
        "title": "Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-faces-severe-selling-pressure-amid-sharp-declines-3729010",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SudarshanPharma_only_sellers_3729010.png",
        "date": "2025-11-25 12:20:57",
        "description": "Sudarshan Pharma Industries has experienced significant selling pressure, with the stock registering a sharp decline of 4.96% today and showing no buying interest. The persistent downward trend over multiple time frames highlights distress selling signals, as the stock trades close to its 52-week low and remains below all key moving averages."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure with 4.97% Daily Decline and 45.91% Year-to-Date Loss.",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-faces-significant-selling-pressure-with-497-daily-decline-and-4591-year-to-date-loss-3711359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SudarshanPharma_only_sellers_3711359.png",
        "date": "2025-11-18 10:30:54",
        "description": "Sudarshan Pharma Industries Ltd is experiencing significant selling pressure, with the stock declining over the past three days. It has underperformed compared to the Sensex across various time frames, including a year-to-date drop of 45.91%. The stock is trading below multiple moving averages, indicating a downward trend."
      }
    ],
    "total": 104,
    "sid": "1003813",
    "stock_news_url": "https://www.marketsmojo.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "02-Dec-2025",
      "details": "Subsequent to approval of the Nomination & Remuneration Committee the Board of Directors of the Company have with effect from 01/December/2025 appointed (i) Mr. Rahul Pandey as the President - Business Operations and Development (Excipients & API Division) and (ii) Mr. Mayank Vyas as the President - Business Development Manager of the Company. Details as per SEBI Circular dated 13/July/2023 are attached with the Companys letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-Oct-2025",
      "details": "Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-September-2025 published in Mumbai Lakshdeep and Financial Express on 20-October-2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "20-Oct-2025",
      "details": "Please find attached copy of certificates received from Kfin Technologies Limited Registrar & Share Transfer Agent under Regulation 74(5) of SEBI (Depository & Participants) Regulations 2018 for the quarter ended 30-September-2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

2025-12-05 08:11:29

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting changes in market sentiment and price dynamics. Recent evaluation adjustments reveal a transition from a bearish to a mildly bearish technical trend, accompanied by mixed signals from key indicators such as MACD, RSI, and moving averages. This article analyses these developments in the context of the company’s price performance and broader market conditions.

Is Sudarshan Pharma technically bullish or bearish?

2025-12-04 08:53:25

Recent Technical Trend Shift

As of 03 Dec 2025, Sudarshan Pharma’s technical trend has transitioned from mildly bearish to outright bearish. This shift signals increased selling pressure and a weakening momentum in the stock’s price action. The change is significant given the stock’s recent price behaviour, which has seen a decline from its previous close of ₹27.28 to a current level near ₹26.35.

The stock’s 52-week high stands at ₹53.50, while the 52-week low is ₹22.33, indicating a wide trading range and substantial volatility over the past year. Today’s intraday range between ₹26.18 and ₹28.00 further highlights the stock’s struggle to regain upward momentum.

Key Technical Indicators Paint a Bearish Picture

Examining the Moving Average...

Sudarshan Pharma Industries: Technical Momentum and Market Assessment Update

2025-12-04 08:12:44

Sudarshan Pharma Industries has experienced a notable shift in its technical momentum, reflecting evolving market dynamics within the specialty chemicals sector. Recent evaluation adjustments reveal a transition from mildly bearish to bearish technical trends, underscoring a complex interplay of price movements and indicator signals that investors should carefully consider.

Sudarshan Pharma Industries Sees Shift in Technical Momentum Amid Market Volatility

2025-12-03 08:09:20

Sudarshan Pharma Industries, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum as recent market data reveals changes in key indicators such as MACD, RSI, and moving averages. The stock’s price movement and technical signals suggest a nuanced market assessment amid broader sector and benchmark trends.

Sudarshan Pharma Industries Sees Unprecedented Buying Interest, Edges Towards Multi-Day Upper Circuit

2025-12-01 14:45:42

Sudarshan Pharma Industries has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the specialty chemicals sector.

Sudarshan Pharma Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-01 10:09:16

Sudarshan Pharma, a microcap player in the Specialty Chemicals sector, has undergone a revision in its market evaluation metrics, reflecting a nuanced view of its recent financial and technical performance. The stock’s assessment now incorporates a blend of stable financial trends, attractive valuation, average quality indicators, and bearish technical signals, providing investors with a comprehensive perspective on its current standing.

Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-28 11:10:57

Sudarshan Pharma Industries has encountered significant selling pressure in the latest trading session, with the stock registering a sharp decline and exhibiting a complete absence of buyers. This distress selling signals heightened investor caution as the stock breaks a four-day streak of gains and trades well below key moving averages.

Sudarshan Pharma Industries Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 12:20:57

Sudarshan Pharma Industries has experienced significant selling pressure, with the stock registering a sharp decline of 4.96% today and showing no buying interest. The persistent downward trend over multiple time frames highlights distress selling signals, as the stock trades close to its 52-week low and remains below all key moving averages.

Sudarshan Pharma Industries Ltd Faces Significant Selling Pressure with 4.97% Daily Decline and 45.91% Year-to-Date Loss.

2025-11-18 10:30:54

Sudarshan Pharma Industries Ltd is experiencing significant selling pressure, with the stock declining over the past three days. It has underperformed compared to the Sensex across various time frames, including a year-to-date drop of 45.91%. The stock is trading below multiple moving averages, indicating a downward trend.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Change in Management

02-Dec-2025 | Source : BSE

Subsequent to approval of the Nomination & Remuneration Committee the Board of Directors of the Company have with effect from 01/December/2025 appointed (i) Mr. Rahul Pandey as the President - Business Operations and Development (Excipients & API Division) and (ii) Mr. Mayank Vyas as the President - Business Development Manager of the Company. Details as per SEBI Circular dated 13/July/2023 are attached with the Companys letter.

Announcement under Regulation 30 (LODR)-Newspaper Publication

20-Oct-2025 | Source : BSE

Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-September-2025 published in Mumbai Lakshdeep and Financial Express on 20-October-2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

20-Oct-2025 | Source : BSE

Please find attached copy of certificates received from Kfin Technologies Limited Registrar & Share Transfer Agent under Regulation 74(5) of SEBI (Depository & Participants) Regulations 2018 for the quarter ended 30-September-2025.